Literature DB >> 25988745

Surgical Success in Chronic Pancreatitis: Sequential Endoscopic Retrograde Cholangiopancreatography and Surgical Longitudinal Pancreatojejunostomy (Puestow Procedure).

Kathryn Ford1, Anu Paul1, Phillip Harrison2, Mark Davenport1.   

Abstract

Introduction Chronic pancreatitis (CP) can be a cause of recurrent, severe, disabling abdominal pain in children. Surgery has been suggested as a useful therapy, although experience is limited and the results unpredictable. We reviewed our experience of a two-stage protocol-preliminary endoscopic retrograde cholangiopancreatography (ERCP) and duct stenting, and if symptoms resolved, definitive surgical decompression by longitudinal pancreatojejunostomy (LPJ) (Puestow operation). Patients and Methods This is a single-center, retrospective review of children with established CP who underwent an LPJ between February 2002 and September 2012. A questionnaire was completed (incorporating visual analog scale pain and lifestyle scores) to assess functional outcome. Data are expressed as median (range). Results In this study, eight (M:F ratio of 4:4) children underwent an LPJ and one female child had a more limited pancreatojejunostomy anastomosis following preliminary ERCP and stent placement where possible. Diagnoses included hereditary pancreatitis (n = 3), idiopathic or structural pancreatitis (n = 5), and duct stricture following radiotherapy (n = 1). Median duct diameter presurgery was 5 (4-11) mm. Endoscopic placement of a Zimmon pancreatic stent was possible in six with relief of symptoms in all. Median age at definitive surgery was 11 (range, 7-17) years with a median postoperative stay of 9 (range, 7-12) days and a follow-up of 6 (range, 0.5-12) years. All children reported markedly reduced episodes of pain postprocedure. One developed diabetes mellitus, while three had exocrine deficiency (fecal elastase < 200 µg/g) requiring enzyme supplementation. The child with limited LPJ had symptomatic recurrence and required restenting and further surgery to widen the anastomosis to become pain free. Conclusion ERCP and stenting provide a therapeutic trial to assess possible benefit of a definitive duct drainage procedure. LPJ-the modified Puestow operation was safe and complication-free with good medium-term relief of symptoms. We were not able to identify a consistent etiology-associated outcome. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 25988745     DOI: 10.1055/s-0035-1551565

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  5 in total

1.  The impact of surgical strategies on outcomes for pediatric chronic pancreatitis.

Authors:  Maria G Sacco Casamassima; Seth D Goldstein; Jingyan Yang; Colin D Gause; Fizan Abdullah; Avner Meoded; Martin A Makary; Paul M Colombani
Journal:  Pediatr Surg Int       Date:  2016-11-04       Impact factor: 1.827

Review 2.  Surgical drainage procedures for paediatric chronic pancreatitis: a scoping review.

Authors:  Tristan Boam; Melissa Gabriel; Bethan G Rogoyski; Ashok Daya Ram; Altaf Awan
Journal:  Pediatr Surg Int       Date:  2022-09-26       Impact factor: 2.003

Review 3.  Paediatric pancreaticobiliary endoscopy: a 21-year experience from a tertiary hepatobiliary centre and systematic literature review.

Authors:  Margaret G Keane; Mayur Kumar; Natascha Cieplik; Douglas Thorburn; Gavin J Johnson; George J Webster; Michael H Chapman; Keith J Lindley; Stephen P Pereira
Journal:  BMC Pediatr       Date:  2018-02-09       Impact factor: 2.125

4.  Increased Risk of Acute Coronary Syndrome in Patients With Chronic Pancreatitis: A Nationwide Cohort Analysis.

Authors:  Ming-Tse Hsu; Cheng-Li Lin; Wei-Sheng Chung
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

5.  Parenchyma Preserving Surgery for Idiopathic Chronic Calcific Pancreatitis in Children: A Report of Three Cases.

Authors:  Tewodross Getu Wolde; Baobao Cai; Guo Feng; Junli Wu; Wentao Gao; Jishu Wei; Yi Miao
Journal:  J Pancreat Cancer       Date:  2019-10-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.